Literature DB >> 1889240

Diagnostic utility of ventilation/perfusion lung scans in acute pulmonary embolism is not diminished by pre-existing cardiac or pulmonary disease.

P D Stein1, R E Coleman, A Gottschalk, H A Saltzman, M L Terrin, J G Weg.   

Abstract

The purpose of this study was to assess the impact of prior cardiac or pulmonary disease upon the utility of ventilation/perfusion (V/Q) scans in the diagnosis of acute pulmonary embolism (PE). Ventilation/perfusion scans were evaluated among 365 patients with no prior cardiac or pulmonary disease and compared to V/Q scans in 526 patients with prior cardiac or pulmonary disease. Among patients with no prior cardiac or pulmonary disease, PE was present in 117 and PE was excluded in 248. Among patients with prior cardiac or pulmonary disease, PE was present in 140 and excluded in 386. The positive predictive value for PE of high probability V/Q scans among patients with prior cardiac or pulmonary disease, 55 of 66 (83 percent), was not significantly lower than among patients without prior cardiac or pulmonary disease, 50 of 54 (93 percent) (NS). The positive predictive value of low probability V/Q scans was similar with prior cardiac or pulmonary disease, 25 of 182 (14 percent), and without prior cardiac or pulmonary disease, 17 of 113 (15 percent) (NS), as was the predictive value of near normal/normal V/Q scans, 2 of 51 (4 percent), vs 3 of 79 (4 percent) (NS). The sensitivity of high probability V/Q scans, with pre-existing cardiac or pulmonary disease and without, 55 of 140 (39 percent) vs 50 of 117 (43 percent), did not differ significantly. The specificity of high probability V/Q scans with prior cardiac or pulmonary disease and without, 375 of 386 (97 percent) vs 244 of 248 (98 percent) was also similar (NS). In conclusion, the diagnostic utility of V/Q scans for acute PE was not impaired by the presence of pre-existing cardiac or pulmonary disease. Fewer patients, however, with no prior cardiac or pulmonary disease, had intermediate (indeterminate) V/Q scans.

Entities:  

Mesh:

Year:  1991        PMID: 1889240     DOI: 10.1378/chest.100.3.604

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Pulmonary scintigraphy at the bedside in intensive care patients with suspected pulmonary embolism.

Authors:  P Jolliet; D O Slosman; B Ricou; P M Suter; J C Chevrolet
Journal:  Intensive Care Med       Date:  1995-09       Impact factor: 17.440

2.  Intravascular ultrasound in patients with acute pulmonary embolism after treatment with intravenous urokinase and high-dose heparin.

Authors:  G Görge; S Schuster; J Ge; J Meyer; R Erbel
Journal:  Heart       Date:  1997-01       Impact factor: 5.994

Review 3.  Assessment of pulmonary embolism.

Authors:  R Erbel; N Wittlich; S Schuster; G Görge; J Ge
Journal:  Int J Card Imaging       Date:  1993

Review 4.  The value of lung scintigraphy in the diagnosis of pulmonary embolism.

Authors:  E J van Beek; M M Tiel-van Buul; H R Büller; E A van Royen; J W ten Cate
Journal:  Eur J Nucl Med       Date:  1993-02

Review 5.  Diagnosis of pulmonary embolism.

Authors:  Clive Kearon
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

6.  Deep vein thrombosis and pulmonary embolism - Prevention, management, and anaesthetic considerations.

Authors:  Krishan Kumar Narani
Journal:  Indian J Anaesth       Date:  2010-01

7.  Pulmonary embolism incidence and fatality trends in chinese hospitals from 1997 to 2008: a multicenter registration study.

Authors:  Yuanhua Yang; Lirong Liang; Zhenguo Zhai; Hangyong He; Wanmu Xie; Xiaoxia Peng; Chen Wang
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

8.  Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.

Authors:  Chen Wang; Zhenguo Zhai; Yuanhua Yang; Qi Wu; Zhaozhong Cheng; Lirong Liang; Huaping Dai; Kewu Huang; Weixuan Lu; Zhonghe Zhang; Xiansheng Cheng; Ying H Shen
Journal:  Chest       Date:  2009-09-09       Impact factor: 9.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.